chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever, headache.  This started at 6pm Feb 5, 2021 and continued until Feb 7, 2021 at 1am.
I am the mother of patient. From the day he was born, patient had been meeting all of his milestones, he was happy, strong, and tried to communicate as much as he could. However, it all changed in October 26th, 2020 after he got the MMR vaccine. By then, I was already aware of all the issues linked to certain vaccines which is why I did not want him to get all of the ones he was due for, instead I just chose that one. This has been the worst mistake of my life. The one that the media won?t say is linked to autism but every mom of an autistic child admits and believes is the vaccine that gave their children autism. After that day, patient had fevers, he was fussy, he stopped making eye contact, he started ignoring us, he would not look at us, he would not listen to his name, started throwing tantrums, and making unique hand movements very close to his eyes. What happened to our healthy and happy child? We just wanted the best for him. MMR VACCINE OCT 26, 2020 CALLED DOC OCT 30, 2020 WITH CONCERN BUT DOC SAID IT WAS TOO EARLY TO DIAGNOSE ANYTHING AUTISM-CONCERN APPT DEC 02, 2020 AUTISM DIAGNOSIS APR 9, 2021
Fatigue, body ache, sore arm and for a short while I felt a little depressed and sensitive and I'm pretty sure it was from the vaccine because I was not feeling like that at all before the shot and it went away in the afternoon.
Initial information received on 02-Oct-2018 regarding an unsolicited valid non-serious case received from a consumer/non-HCP. This case involves a 30 years old female patient who was exposed to vaccine ADACEL in context of administered to a pregnant patient. The reported administered to a pregnant patient. Occurred at unknown gestation period and the patient was exposed to DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE at 7 weeks of pregnancy, during first pregnancy trimester for DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. The date of last menstrual period was reported as 29-Aug-2018. The estimated due date is 05-Jun-2019. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Oct-2018, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U5658A via intramuscular route in the left deltoid. The patient developed a non-serious administered to a pregnant patient. (Exposure during pregnancy) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. (Other relevant tests included No lab data). Final diagnosis was administered to a pregnant patient. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Not Applicable for administered to a pregnant patient. Additionally, at time of reporting, the pregnancy is still ongoing. Documents held by sender: none.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a adult male patient who received SHINGRIX (batch number 7X743, expiry date 22nd May 2021) and (batch number TZ2578, expiry date 6th July 2021) for prophylaxis. In December 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the dose was an unknown dose. On an unknown date, 21 days after receiving SHINGRIX, the patient experienced rash. The patient was treated with prednisone. On an unknown date, the outcome of the rash was recovering/resolving.  It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported, however it could be 69 or 70 years. The reported batch number TZ2578 seems to be adjuvant's batch number was not available in sales data base, however it was captured as TZ2578 ? The patient developed a rash on his back. The patient was given a course of prednisone and rash was resolving. No additional details were provided at the time of the call.
17JUN93 approx 430PM t104 R; pt vomits x 2 during early evening; 1015PM went to ER t100.9 R vomited x 1 1135PM, t104 R; pt admitted redness & swelling rt leg @ site approx 25 cents to 50 cents size;
Within 2 1/2 hrs, developed shaking chills, whole body ached. Went to E.D. Left arm remains sore 11/30/15 and regular visit to physician office.
This spontaneous report as received from a nurse practitioner refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ, orally, lot # M018957, expiration date 22-NOV-2017 (exact dose was not reported). There was no adverse effect reported. Administered doses of vaccine experienced a temperature excursion of 34 Fahrenheit degrees for 1 hour. There were no previous temperature excursions. Data logger was not involved. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA007729.
10/5/16 pm-Arm extremely sore. 10/6/16 am-Unable to lift arm for several days. Ongoing-Pain in arm when sleeping, still hard to lift arm over head.
-Severe soreness in injection area lasting 3-days -101 fever starting 18-hours after vaccination and lasting 10-hours -Fatigue of whole body lasting 3-days -Loss of appetite lasting 2-days -Acute soreness in both shoulders that have existing tendonitis and in right ankle that has existing arthritis lasting 2-days -Internal lower abdominal pain  starting 2-days after shot and lasting 24-hours
Initial information received on 24-Oct-2018 regarding an unsolicited valid non-serious case received from a Pharmacist. This case involves an 80 years old patient (gender not reported) who received a dose of 0.5 ml dose of vaccine FLUZONE HIGH DOSE (lot number not reported) via unknown route in unknown administration site on 24-Oct-2018 and another dose one month apart. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. No other vaccine were given. It was a case of actual medication error due to extra dose administered. It was reported that the patient had no significant reaction with the first dose. It was not reported if patient had any adverse event following extra dose. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
I believe that the vaccine could have affected my monthly menstrual cycle (particularly ovulation), which (if it is documented by enough women) I feel should be looked into more so more women are aware. I've been tracking my period/ovulation for months for family planning purposes. I had 1st dose of Moderna vaccine on 1/20/21 and my next period on 1/28/21. I've been using OPK tests to track ovulation over the past few months, which have been positive on cycle day 18 or cycle day 19 (it's never been outside of those days before). When  I tested using the OPK twice per day on 2/10/21 (Cycle day 14) through 2/17/21 (cycle day 21), I got all negatives. I have no idea when I actually ovulated in February and think that the vaccine may have moved the date up earlier (which never happened). I know that I ovulated sometime, since I got a very happy surprise positive pregnancy test on 2/25/21 (which conflicts with the infertility myths!). While our family is thrilled with the news, I wanted to report it to VAERS in case there could be a possibility that the covid vaccine could throw off somebody's menstrual cycles/ovulation. If there is a link between those two, I feel like women of childbearing age would want to be informed of that possibility!
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 70-year-old female patient received BNT162b2 (BNT162B2), on 07Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (ongoing). Concomitant medication(s) included: LOSARTAN taken for hypertension; AMLODIPINE taken for hypertension. Vaccination history included: BNT162b2 (Dose 1, single; Anatomical Location: Left arm), administration date: 06Mar2021, when the patient was 70-year-old, for COVID-19 Immunization, reaction(s): "High fever", "Chills", "Achy all over"; BNT162b2 (Dose 2, single; Lot number: EP7534; Anatomical Location: Left arm), administration date: 27Mar2021, when the patient was 70-year-old, for COVID-19 Immunization, reaction(s): "High fever", "Chills", "Achy all over". The following information was reported: CHILLS (non-serious) with onset Oct2021, outcome "unknown"; PYREXIA (non-serious) with onset Oct2021, outcome "unknown", described as "High fever/ high fever temperature"; PAIN (non-serious) with onset Oct2021, outcome "unknown", described as "achy all over". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia, chills, pain. Additional information: Consumer (Patient) stated that she had a very high fever temperature after each one. She stated, "High fever, chills, achy all over for approximately 24 hours on each of those". For those 2 vaccines and the 2 boosters. Patient stated the booster is I can't read her write it's looks like Pfizer FF2580 or 89 and the last one was I can't read this; I can't read it." Patient stated, she had no laboratory tests, not within 1 or 2 weeks. She stated that she received Tylenol "100 milligram" as treatment for adverse event. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report was received from a doctor of pharmacy refers to a patient of unknown age who on 26-FEB-2013, was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not reported). The pharmacist reported that the patient received less than the required dose of ZOSTAVAX (due to syringe or needle leakage). It was stated that during administration of the ZOSTAVAX a couple of drops came out of the syringe and ran down the needle. No adverse events were reported. Additional information is not expected.
Received a call from mom stating pt had H1N1 #2 this am and mom noticed her hands and body trembling at lunchtime. Pt ate lunch. No diff breathing or other sxs. Mom to cb for ongoing pos.
Dizziness, lightheadedness mild nausea approximately 24 hours post vaccine.
Patient had itching after administration, the itching continued throughout the next week. 6 days after immunization a hard, red, hot nodule appeared at injection site along with severe itching and rash/hives. Patient was advised to use a cold compress and take anti-histamine such as Benadryl.
Patient stated she had soreness at injection site, but on day 2 after vaccination (3/7/2018) the injection site was red and swollen to the size of a baseball. She said the redness and swelling has stopped without treatment and could not tell me an exact timeframe, but she continues to have soreness in her right arm.
Starting Saturday morning to current: Swelling of left lymph nodes of armpit to the size of a lime. Pain at a 6.5/10 for the lymph nodes only. Constant, stabbing pain minimally relieved with Tylenol and heat.
warm, red, raised, hard lump approximately diameter of a tennis ball on the right thigh at site of DTAP/HIB. No apparent discomfort at site, no fever noted.
Immediately after giving vaccines, both thighs developed red area 4" by 3" to right thigh 3" by 3" to (L) thigh - both areas warm to touch. 12:50 PM - (L) thigh resolved. Called Mom 2 hrs. later, redness resolved.
Adverse event reported was herpes zoster to left side with ocular involvement that occurred two days after second dose of the COVID 19 vaccine. Treatment with Valtrex 1g TID with erythromycin ointment over skin lesions. Patient also had associated fever one day after vaccine around 100.0deg F.  has since resolved with treatment.
fainted after receiving TRUMENBA; This is a spontaneous report from a contactable other health professional via Pfizer Sales Representative. This other health professional reported similar events for two patients. This is the first of two reports.  A 16-year-old male patient received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration, on an unspecified date (Batch/lot number and expiration date not reported), as dose number unknown, single, for immunization. Relevant medical history and concomitant medications were not reported. On an unspecified date, the patient fainted after receiving TRUMENBA. The reporter stated that she had two patients who were unrelated approximately aged 16 and 17 who fainted after receiving TRUMENBA. One of these patients received GARDACIL in the same visit, the reporter could not remember which one. The reporter stated that she reported this at the time of the incident, and since had several cases of dizziness and pain from additional patients who received TRUMENBA. They are no longer using TRUMENBA due to this. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: A possible contributory role of the suspect products cannot be excluded for the reported events faint based on the known safety profile and temporal association ,Linked Report(s) : US-PFIZER INC-202101076778 same reporter, suspect product, event; different patients
Fatigue after 2nd dose; This spontaneous case was reported by a nurse and describes the occurrence of FATIGUE (Fatigue after 2nd dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced FATIGUE (Fatigue after 2nd dose). On 05-Mar-2021, FATIGUE (Fatigue after 2nd dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medications were provided No  Concomitant medications were provided   This case was linked to MOD-2021-374898, MOD-2021-374915 (Patient Link).
5.5.21: chills, fever, muscle aches, fatigue. 5.6.21: redness and swelling on left side of face under left eye.
The staff member administered the diluent only for the varicella vaccine. The staff noted this after administration, notified the provider, the provider explained to the patient/parents, and the varicella vaccine was then correctly administered.
Fever; This is a spontaneous report from a contactable physician. A 17-year-old female patient started to received meningococcal group b rlp2086 (TRUMENBA, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at a SINGLE DOSE for immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, a physician mentioned that she administered the first dose of the Trumenba vaccine to a 17 year old patient last Saturday and the patient was still having fever. She would like to know if there was record of fever lasting this long. The outcome of the event was unknown.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
neurological side effects; Paresthesia, the tingling in the legs and in arms and the tongue, both leg, both arms and the tongue; Paresthesia, the tingling in the legs and in arms and the tongue, both leg, both arms and the tongue; This is a spontaneous report from a contactable consumer (patient). A 45-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EW0177 and Expiration date: unknown), dose 2 via intramuscular route, administered in left arm on 21May2021 15:30 as SINGLE DOSE for covid-19 immunisation. The patient had no medical history and concomitant medications. Patient previously received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EW0172 and Expiration date: unknown), dose 1 via intramuscular route, administered in left arm on 30Apr2021 15:30 as single dose for covid-19 immunisation. Patient has not received any other vaccine 4 weeks prior to COVID-19 vaccine. In May2021 (within 24 hours after second shot), the patient reported that she was going to ER (today as reported) to see neurologist because she experienced neurological side effects, paresthesia, the tingling in the legs and in arms and the tongue, both legs, both arms and the tongue. The patient underwent lab tests and procedures which included blood work with unknown results on an unknown date. Outcome of events was unknown.
THE PATIENT COMPLAINED OF DIZZINESS AFTER THE ADMINISTRATION. THE PATIENT EXPLAINED THAT ANY TIME HE RECEIVES A SHOT HE BECOMES LIGHT HEADED. THE PATIENT WAS LAID ON A STRETCHER FOR A PERIOD OF TIME AT WHICH THE PATIENT EXPLAINED HE FELT BETTER. THE PATIENT EXPLAINED THAT HE DID NOT WANT TO GO TO THE HOSPITAL.
Less than 10 hours after getting the shot on 12/14 I got my period, even though my last period had ended 12/5--only 9 days prior. It lasted for 6 days, which was longer than usual, though it wasn't as heavy as normal. My regular cycle is about 35 days, yet I got my next period on January 4th--a week earlier than I should've gotten it if I hadn't gotten an extra period and and over 2 weeks earlier when I take the extra period into account. I also experienced a terrible fever, chills, muscular aching from my neck to the arches of my feet, chronic joint pains, brain fog and concentration issues, and gastrointestinal pains including nausea and diarrhea starting about 12 hours after 12/14 and lasting through the night. The aches, fever, and brain fog/concentration issues lasted for a few days; by day three my joints and muscles were still in awful condition and I was unable to catch my breath on a short routine walk. In high school, I was a 3 sport athlete, and throughout college I was heavily involved with my school's marching band. Breath support has never been a problem for me.  All told, I didn't feel back to normal until about 12/20, and even then I was a bit easily worn out. Immediately before the vaccine I had not gotten Covid, and on that day, I took an at-home Covid test and got a negative result.
At 6 pm, she started with epistaxis (nose bleeding), and all of her normal medical problems seemed amplified, whereby she had bright lights in her eyes, fatigue, dizziness, and the next day, she developed flu like symptoms, her fingers went numb several times and her heart palpitations were worse, and she felt like she was going to pass out. These symptoms lasted the whole next day. She has not felt well since and for this reason does not wish to take the booster.
Patient presented to the ED and was subsequently hospitalized for Compression fracture of T12 vertebra,  Compression fracture of first lumbar vertebra within 6 weeks of receiving covid vaccination.
Slow and slurred speech Shortness of breath Slow chewing Fatigue and weakness Sometimes problem in swallowing liquids
about 5 minutes after administering, patient stood up and said he was getting tunnel vision.  moments later he fell to the floor. I kept him there lying until he was able to sit.  He was conscious the entire time and could state his name and day of week. He was given orange juice and a muffin. We observed him for approximately 45 minutes. He declined EMS.
Patient had normal pelvic exam (per Dr Ob/Gyn) in July 08 and was started on GARDASIL vaccine. About 3 weeks after 1st shot, she developed lesions on her perineum. She denied new sexual partner or any known exposure to HPV/genital warts. 7-10-08 <- Presented to Gyn clinic with 6 genital warts 2-4mm in size on right upper labia majora. Triacetic Acid applied. Aldora Topical 3-4 days after (TCA) burning - resolves. Above treatment started 9-10-08.
Information has been received from a physician concerning a 16 year old female who was vaccinated intramuscularly with a 0.5 ml dose of GARDASIL. It was reported that sometime after she got the vaccine the patient had been having "fainting spells." The patient sought unspecified medical attention and went to an emergency room but was not admitted. The doctor reported that since the patient was continuing to faint then it was a significant disability/incapacity. At the time of reporting the patient was not recovered. Additional information has been requested.
RN that was calling to report temperature excursion that was intermittent beginning 7/28/2020, but not previously reported, involving PROQUAD states that there have been administered doses.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  Since 28-JUL-2020, measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) had intermittent temperature excursion between a temperature of -14 degrees Celsius (C) to -10C (max -9.5C) for 38 hours and 30 minutes, as recorded by a data logger. There was no previous temperature excursion.  On 17-AUG-2020, the patient was administered an improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (0.5 milliliter (ml), lot # T009929, expiration date 16-SEP-2021, strength and route were not provided) for prophylaxis (product storage error).
Was administered the anthrax shot (5th dose) and broke out with a rash that would not go away.
Information has been received from a registered nurse concerning a 10 week old formula fed female with no medical history or allergies who on 18-APR-2007 was vaccinated with a 2 ml oral dose of Rotateq (lot # 656196/0026U). There was no concomitant medication. On 21-APR-2007 the patient developed vomiting. She was seen in the ER that day. She was admitted to the hospital with intussusception. Barium procedure to open the bowel was unsuccessful. Surgery was required. On 23-APR-2007 the baby was discharged from the hospital. At the time of the report the patient was recovering. There was no product quality complaint involved. The patient's intussusception was considered to be life threatening and an other important medical event. Additional information has been requested.  05/29/2007  MR received for 2 night ER admit for c/o abdominal pain, vomiting and bloody diarrhea.  Hx of diarrhea x 5 days prior to emesis and bloody diarrhea.  PE: Irritable infant in moderate distress. Abdomen distended, tender to palpation.  Unable to reduce with BE so pt. had surgical reduction of ileocolic intussusception and appendectomy. Final DX:  Intussusception.
The pt experienced cellulitis at the left deltoid with redness and pain. The pt was prescribed Keflex but didn't improve.
Patient received 1st dose of mRNA COVID-19 vaccine on 4/15 and it was Pfizer and then received Moderna mRNA COVID-19 vaccine on 5/14.  This was suppose to be the second dose of Pfizer.
Patient was mistakenly give 0.1ml instead of 0.5ml Patient was notified and will restart his vaccinations today.